Global Embolic Protection Devices for Carotid Artery Stenting market cagr 13.2%

Page 1


Embolic Protection Devices for Carotid Artery

Stenting Market

Embolic Protection Devices for Carotid Artery

Stenting Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031

Request Sample Report

Embolic Protection Devices for Carotid Artery Stenting Market Size and Growth

The Embolic Protection Devices for Carotid Artery Stenting market is experiencing growth driven by rising cardiovascular disease prevalence and advancements in minimally invasive procedures. As of 2023, the market size is estimated to reach USD 320 million, reflecting increased adoption and innovative device technologies that enhance patient outcomes and procedural safety.

Request Sample Report

Companies Covered (Covid 19 Impact Covered)

◍ Boston Scientific (Claret Medical)

◍ Venus Medtech (Keystone Heart)

◍ Transverse Medical

◍ Innovative Cardiovascular Solutions

◍ Protembis GmbH

◍ Filterlex Medical

◍ Emboline

The Embolic Protection Devices for Carotid Artery Stenting Market features major players like Boston Scientific, Venus Medtech, Transverse Medical, Innovative Cardiovascular Solutions, Protembis GmbH, Filterlex Medical, and Emboline. These companies enhance market growth through innovative device offerings, improving safety and efficacy in carotid artery procedures, driving sales and adoption. Sales figures include:

- Boston Scientific: $3.5 billion

- Filterlex Medical: not publicly disclosed

- Venus Medtech: $270 million.

Request Sample Report

Market Segmentation

By Application

Hospital

Clinic

Others

Request Sample Report

By Product

Distal Occlusion Devices

Proximal Occlusion Devices

Market Growth

Request Sample Report

$ X Billion USD

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
Global Embolic Protection Devices for Carotid Artery Stenting market cagr 13.2% by ReportPrime - Issuu